Cargando…

Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study

INTRODUCTION: The presence of late gadolinium enhancement (LGE) at the right ventricular insertion point (RVIP) on cardiac magnetic resonance (CMR) is generally believed to be nonspecific, but the clinical implication of this unique LGE pattern in patients with non-ischemic dilated cardiomyopathy (N...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Jeong-Eun, Park, Junbeom, Lee, Hye-Jeong, Shin, Dong Geum, Kim, Yookyung, Kim, Minsuk, Kwon, Kihwan, Pyun, Wook Bum, Kim, Young Jin, Joung, Boyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261623/
https://www.ncbi.nlm.nih.gov/pubmed/30485353
http://dx.doi.org/10.1371/journal.pone.0208100
_version_ 1783374981689769984
author Yi, Jeong-Eun
Park, Junbeom
Lee, Hye-Jeong
Shin, Dong Geum
Kim, Yookyung
Kim, Minsuk
Kwon, Kihwan
Pyun, Wook Bum
Kim, Young Jin
Joung, Boyoung
author_facet Yi, Jeong-Eun
Park, Junbeom
Lee, Hye-Jeong
Shin, Dong Geum
Kim, Yookyung
Kim, Minsuk
Kwon, Kihwan
Pyun, Wook Bum
Kim, Young Jin
Joung, Boyoung
author_sort Yi, Jeong-Eun
collection PubMed
description INTRODUCTION: The presence of late gadolinium enhancement (LGE) at the right ventricular insertion point (RVIP) on cardiac magnetic resonance (CMR) is generally believed to be nonspecific, but the clinical implication of this unique LGE pattern in patients with non-ischemic dilated cardiomyopathy (NICM) has not been elucidated. OBJECTIVES: We investigated the prognostic significance of RVIP-LGE in NICM patients. METHODS: A total of 360 consecutive NICM patients referred for CMR (102 with no LGE, 50 with RVIP-LGE, 121 with left ventricular [LV]-LGE, and 87 with both an LV and RVIP-LGE) were studied. The primary endpoint was a composite of the all-cause death, hospitalization due to worsening of heart failure, and major arrhythmic events. RESULTS: During a mean follow-up of 45.2 ± 36.5 months, 149 (41.4%) patients (22 [21.6%] no LGE vs. 16 [32.0%] RVIP-LGE vs. 62 [51.2%] LV-LGE vs. 49 [56.3%] both LV and RVIP-LGE, P < 0.0001) reached the primary endpoint. A Kaplan Meier curve demonstrated that RVIP-LGE patients had an intermediate trend of an event free survival rate for the composite endpoint (log-rank P < 0.0001). In a multivariable Cox regression model, LV-LGE (P = 0.008) and both LV and RVIP-LGE (P = 0.003) were significantly associated with a worse outcome, whereas RVIP-LGE was not (P = 0.101). In addition, RVIP-LGE patients (n = 32) had a more favorable outcome compared to LV-LGE patients (n = 32) even after matching the extent of the LGE (median 3.4% [interquartile range, 3.1–3.8], 8 [25.0%] RVIP-LGE vs. 20 [62.5%] LV-LGE, P = 0.002). CONCLUSIONS: LGE confined to the RVIP among NICM patients did not significantly increase the risk of adverse cardiac events, and also showed a better outcome than the same extent of LGE located in the LV. Identification of this unique LGE distribution may help refine the current risk stratification.
format Online
Article
Text
id pubmed-6261623
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-62616232018-12-19 Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study Yi, Jeong-Eun Park, Junbeom Lee, Hye-Jeong Shin, Dong Geum Kim, Yookyung Kim, Minsuk Kwon, Kihwan Pyun, Wook Bum Kim, Young Jin Joung, Boyoung PLoS One Research Article INTRODUCTION: The presence of late gadolinium enhancement (LGE) at the right ventricular insertion point (RVIP) on cardiac magnetic resonance (CMR) is generally believed to be nonspecific, but the clinical implication of this unique LGE pattern in patients with non-ischemic dilated cardiomyopathy (NICM) has not been elucidated. OBJECTIVES: We investigated the prognostic significance of RVIP-LGE in NICM patients. METHODS: A total of 360 consecutive NICM patients referred for CMR (102 with no LGE, 50 with RVIP-LGE, 121 with left ventricular [LV]-LGE, and 87 with both an LV and RVIP-LGE) were studied. The primary endpoint was a composite of the all-cause death, hospitalization due to worsening of heart failure, and major arrhythmic events. RESULTS: During a mean follow-up of 45.2 ± 36.5 months, 149 (41.4%) patients (22 [21.6%] no LGE vs. 16 [32.0%] RVIP-LGE vs. 62 [51.2%] LV-LGE vs. 49 [56.3%] both LV and RVIP-LGE, P < 0.0001) reached the primary endpoint. A Kaplan Meier curve demonstrated that RVIP-LGE patients had an intermediate trend of an event free survival rate for the composite endpoint (log-rank P < 0.0001). In a multivariable Cox regression model, LV-LGE (P = 0.008) and both LV and RVIP-LGE (P = 0.003) were significantly associated with a worse outcome, whereas RVIP-LGE was not (P = 0.101). In addition, RVIP-LGE patients (n = 32) had a more favorable outcome compared to LV-LGE patients (n = 32) even after matching the extent of the LGE (median 3.4% [interquartile range, 3.1–3.8], 8 [25.0%] RVIP-LGE vs. 20 [62.5%] LV-LGE, P = 0.002). CONCLUSIONS: LGE confined to the RVIP among NICM patients did not significantly increase the risk of adverse cardiac events, and also showed a better outcome than the same extent of LGE located in the LV. Identification of this unique LGE distribution may help refine the current risk stratification. Public Library of Science 2018-11-28 /pmc/articles/PMC6261623/ /pubmed/30485353 http://dx.doi.org/10.1371/journal.pone.0208100 Text en © 2018 Yi et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Yi, Jeong-Eun
Park, Junbeom
Lee, Hye-Jeong
Shin, Dong Geum
Kim, Yookyung
Kim, Minsuk
Kwon, Kihwan
Pyun, Wook Bum
Kim, Young Jin
Joung, Boyoung
Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study
title Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study
title_full Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study
title_fullStr Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study
title_full_unstemmed Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study
title_short Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study
title_sort prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: a multicenter retrospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261623/
https://www.ncbi.nlm.nih.gov/pubmed/30485353
http://dx.doi.org/10.1371/journal.pone.0208100
work_keys_str_mv AT yijeongeun prognosticimplicationsoflategadoliniumenhancementattherightventricularinsertionpointinpatientswithnonischemicdilatedcardiomyopathyamulticenterretrospectivecohortstudy
AT parkjunbeom prognosticimplicationsoflategadoliniumenhancementattherightventricularinsertionpointinpatientswithnonischemicdilatedcardiomyopathyamulticenterretrospectivecohortstudy
AT leehyejeong prognosticimplicationsoflategadoliniumenhancementattherightventricularinsertionpointinpatientswithnonischemicdilatedcardiomyopathyamulticenterretrospectivecohortstudy
AT shindonggeum prognosticimplicationsoflategadoliniumenhancementattherightventricularinsertionpointinpatientswithnonischemicdilatedcardiomyopathyamulticenterretrospectivecohortstudy
AT kimyookyung prognosticimplicationsoflategadoliniumenhancementattherightventricularinsertionpointinpatientswithnonischemicdilatedcardiomyopathyamulticenterretrospectivecohortstudy
AT kimminsuk prognosticimplicationsoflategadoliniumenhancementattherightventricularinsertionpointinpatientswithnonischemicdilatedcardiomyopathyamulticenterretrospectivecohortstudy
AT kwonkihwan prognosticimplicationsoflategadoliniumenhancementattherightventricularinsertionpointinpatientswithnonischemicdilatedcardiomyopathyamulticenterretrospectivecohortstudy
AT pyunwookbum prognosticimplicationsoflategadoliniumenhancementattherightventricularinsertionpointinpatientswithnonischemicdilatedcardiomyopathyamulticenterretrospectivecohortstudy
AT kimyoungjin prognosticimplicationsoflategadoliniumenhancementattherightventricularinsertionpointinpatientswithnonischemicdilatedcardiomyopathyamulticenterretrospectivecohortstudy
AT joungboyoung prognosticimplicationsoflategadoliniumenhancementattherightventricularinsertionpointinpatientswithnonischemicdilatedcardiomyopathyamulticenterretrospectivecohortstudy